Sunday, May 31, 2020 10:02:19 AM
2020-05-07 13D/A Eight Corp Ltd 12,045,332 29.20
2019-08-01 13D Cotterford Co Ltd 12,041,570 29.30
2019-02-25 13G/A Hever Investments Ltd 11,877,476 29.40
2019-02-14 13G/A Lagoda Investment Management, L.P. 1,643,714 4.70
2019-02-11 13D/A Innes Guy Archibald 1,875,701 5.30
2018-11-09 13D/A Faulkes Martin Charles 1,977,284 5.60
2018-11-09 13D/A Reynolds Cameron John 2,562,967 7.20
2017-02-08 13G/A MANCHESTER MANAGEMENT CO LLC 1,212,159 4.60
2016-12-29 13D Hunt David 63,440,000 62.30
Recent VNRX News
- Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems • PR Newswire (US) • 03/06/2026 01:10:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:32:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:32:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:32:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:31:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:31:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:30:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:30:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:30:29 PM
- VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution • PR Newswire (US) • 02/25/2026 01:10:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2026 10:15:32 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/20/2026 05:15:15 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 02/11/2026 10:05:44 PM
- Volition Announces the Appointment of New Distributor for Nu.Q® Discover • PR Newswire (US) • 02/10/2026 01:07:00 PM
- VolitionRx Receives Notice of Non-Compliance with NYSE American Continued Listing Standards • PR Newswire (US) • 02/09/2026 10:20:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 02/09/2026 10:16:09 PM
- Volition Sponsors Symposium at 15th Conference of the European Hidradenitis Suppurativa Foundation • PR Newswire (US) • 02/04/2026 01:45:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/03/2026 09:05:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/03/2026 09:05:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/03/2026 09:05:05 PM
- VolitionRx Limited Announces the Preparation of Reimbursement Submission for its Nu.Q® Cancer Assays • PR Newswire (US) • 01/30/2026 01:50:00 PM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
